
Opinion|Podcasts|May 14, 2024
Focusing in on Novel Oral Systemic Therapies for Moderate Plaque Psoriasis
Listen
0:00 / 0:00
Lauren Miller, MPAS, PA-C, leads an expert discussion surrounding exciting developments in the treatment landscape of plaque psoriasis.
Advertisement
00:00 Introduction
03:15 The role of APP’s in getting patients access to dermatological care.
06:06 Managing patients with suboptimal controlled plaque psoriasis
13:05 Breaking down barriers to access new treatments for plaque psoriasis.
20:23 Deciding between oral and injectable systemic therapies.
24:25 The mechanism of action of TYK-2 inhibitors
28:24 The safety profile of deucravacitinib
33:14 Monitoring your patients with plaque psoriasis
38:50 Outro
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy
2
Bimekizumab Data Support Case for Earlier Intervention in HS
3
A Genetic Signature May Predict Who Gets Sick From CAR T Cell Therapy
4
Rethinking HFpEF Screening and Care, With Ronald D'Agostino, DO
5







































































